{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:55:32Z","timestamp":1790294132870,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Prostate cancer (PCa) originating from the prostate base may intrude into the urinary bladder and may be misdiagnosed as bladder cancer. In this retrospective study, we reviewed the clinic data on PCa cases which were initially misdiagnosed as bladder cancer in order to identify diagnostic methods that would allow a better differential diagnosis for PCa.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Out of a total of 455 patients treated for PCa at our hospital between April 2003 and June 2011, 14 patients (3.1%) had been initially misdiagnosed as urinary bladder urothelial cell carcinoma. The clinical data on these 14 cases was retrieved and analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 14 patients, 11 patients were eventually diagnosed with PCa after MRI examination, and seven out of these had PCa with bladder neck invasion. Prostate needle biopsy or transurethral resection of prostate (TURP) revealed that all 14 patients had adenocarcinoma of prostate with Gleason scores ranging from 7 to 9. Nine patients received TURP for hematuria or lower urinary tract blockage. The mean follow-up was 37\u00a0months, during which six patients survived.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>As clinical presentation and in emergency settings, prostate cancer originating from the prostate base can be confused with bladder cancer originating from the neck or the triangle region of the urinary bladder. Serum prostate specific antigen (PSA) levels and digital rectal examination, in combination with transrectal ultrasound (TRUS), MRI, and prostate needle biopsy are valuable tools for definitive differential diagnosis of the basal prostate cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/2047-783x-18-36","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T09:02:00Z","timestamp":1380790920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder"],"prefix":"10.1186","volume":"18","author":[{"given":"Ranlu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,3]]},"reference":[{"key":"63_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61: 69\u201390. 10.3322\/caac.20107","journal-title":"CA Cancer J Clin"},{"key":"63_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pros.2990020105","volume":"2","author":"JE McNeal","year":"1981","unstructured":"McNeal JE: The zonal anatomy of the prostate. Prostate 1981, 2: 35\u201349.","journal-title":"Prostate"},{"key":"63_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1309\/4T6H-549R-CAPJ-FEY0","volume":"113","author":"B Krishnan","year":"2000","unstructured":"Krishnan B, Truong LD: Prostatic adenocarcinoma diagnosed by urinary cytology. Am J Clin Pathol 2000, 113: 29\u201334. 10.1309\/4T6H-549R-CAPJ-FEY0","journal-title":"Am J Clin Pathol"},{"key":"63_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2559.2003.01560.x","volume":"42","author":"M Varma","year":"2003","unstructured":"Varma M, Morgan M, Amin MB, Wozniak S, Jasani B: High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology 2003, 42: 167\u2013172. 10.1046\/j.1365-2559.2003.01560.x","journal-title":"Histopathology"},{"key":"63_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2559.2005.02188.x","volume":"47","author":"M Varma","year":"2005","unstructured":"Varma M, Jasani B: Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology 2005, 47: 1\u201316. 10.1111\/j.1365-2559.2005.02188.x","journal-title":"Histopathology"},{"key":"63_CR6","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/PAS.0b013e31802f5d33","volume":"31","author":"AY Chuang","year":"2007","unstructured":"Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI: Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol 2007, 31: 1246\u20131255. 10.1097\/PAS.0b013e31802f5d33","journal-title":"Am J Surg Pathol"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000472079","volume":"3","author":"JA Martinez-Pineiro","year":"1977","unstructured":"Martinez-Pineiro JA, Muntanola P, Martin MG, Hidalgo L: Fluorescence urinary cytology in bladder cancer. Eur Urol 1977, 3: 142\u2013144.","journal-title":"Eur Urol"},{"key":"63_CR8","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/1097-0142(19940901)74:5<1621::AID-CNCR2820740521>3.0.CO;2-E","volume":"74","author":"SS Raab","year":"1994","unstructured":"Raab SS, Lenel JC, Cohen MB: Low-grade transitional cell carcinoma of the bladder. cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994, 74: 1621\u20131626. 10.1002\/1097-0142(19940901)74:5<1621::AID-CNCR2820740521>3.0.CO;2-E","journal-title":"Cancer"},{"issue":"4","key":"63_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1590\/S1677-55382004000400005","volume":"30","author":"FR Romero","year":"2004","unstructured":"Romero FR, De Castro MG, Andriolo J\u00fanior A, De Meneses AH, Fernandes RC, Perez MD: Coexistence of prostate neoplasia in patients undergoing radical cystoprostatectomy due to vesical neoplasia. Int Braz J Urol 2004, 30(4):296\u2013301. 10.1590\/S1677-55382004000400005","journal-title":"Int Braz J Urol"},{"issue":"2","key":"63_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.urology.2009.03.010","volume":"74","author":"R Mazzucchelli","year":"2009","unstructured":"Mazzucchelli R, Barbisan F, Santinelli A, Scarpelli M, Galosi AB, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R: Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer. Urology 2009, 74(2):385\u2013390. 10.1016\/j.urology.2009.03.010","journal-title":"Urology"},{"issue":"1","key":"63_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/aja.2012.111","volume":"15","author":"P Tang","year":"2013","unstructured":"Tang P, Chen H, Uhlman M, Lin YR, Deng XR, Wang B, Yang WJ, Xie KJ: A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer. Asian J Androl 2013, 15(1):129\u2013133. 10.1038\/aja.2012.111","journal-title":"Asian J Androl"},{"issue":"2","key":"63_CR12","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1259\/bjr\/11253478","volume":"78","author":"H Hricak","year":"2005","unstructured":"Hricak H: MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005, 78(2):S103-S111.","journal-title":"Br J Radiol"},{"key":"63_CR13","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1158\/1078-0432.CCR-11-2048","volume":"17","author":"K Contractor","year":"2011","unstructured":"Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, et al.: Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression. Clin Cancer Res 2011, 17: 7673\u20137683. 10.1158\/1078-0432.CCR-11-2048","journal-title":"Clin Cancer Res"},{"key":"63_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0022-5347(05)64024-4","volume":"169","author":"BR Matlaga","year":"2003","unstructured":"Matlaga BR, Eskew LA, McCullough DL: Prostate biopsy: indications and technique. J Urol 2003, 169: 12\u201319. 10.1016\/S0022-5347(05)64024-4","journal-title":"J Urol"},{"issue":"8","key":"63_CR15","doi-asserted-by":"publisher","first-page":"E365","DOI":"10.1111\/bju.12134","volume":"111","author":"K Ekwueme","year":"2013","unstructured":"Ekwueme K, Simpson H, Zakhour H, Parr NJ: Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int 2013, 111(8):E365-E373. 10.1111\/bju.12134","journal-title":"BJU Int"},{"key":"63_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988, 12: 897\u2013906. 10.1097\/00000478-198812000-00001","journal-title":"Am J Surg Pathol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-18-36.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:38:49Z","timestamp":1630546729000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/2047-783X-18-36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,3]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1186\/2047-783x-18-36","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,3]]},"assertion":[{"value":"11 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"36"}}